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http://dx.doi.org/10.1016/j.jmii.2013Background: Tuberculosis (TB), caused by the Mycobacterium tuberculosis complex (MTBC), is
a serious infection in humans and animals. Ethiopia is one of the countries in Sub-Saharan Af-
rica with the highest burden of TB. However, limited information is available on the genotypic
characteristics of M. tuberculosis strains infecting humans. The objective of the present study
was to characterize the mycobacterial species isolated from pulmonary TB patients using mo-
lecular typing.
Materials and methods: A cross-sectional study was conducted on 123 patients with smear-
positive pulmonary TB, using Ziehl Neelsen staining and bacteriological culturing. Molecular
characterizations of the mycobacterial isolates were performed using region of difference 9
(RD9) deletion typing and spoligotyping methods.
Results: The proportion of culture positivity was 95.9% (118/123). All the 118 isolates were
confirmed to be M. tuberculosis by polymerase chain reaction-based RD9 deletion typing.
Further characterization of all isolates using spoligotyping resulted in the identification of
36 different spoligotype patterns. Out of these, 32 (88.9%) patterns have already been re-
ported in the SpolDB database, whereas the remaining four (11.1%) patterns were new andof Microbiology, Immunology, and Parasitology, College of Medicine and Health Sciences, Bahir Dar
com (T. Debebe).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
.03.012
334 T. Debebe et al.not registered in the database. The isolates were further grouped into 17 clustered (99 iso-
lates) and 19 nonclustered patterns. The most predominant spoligotypes were SIT25 and
SIT53, consisting of 22 isolates and 14 isolates, respectively. Classification of the spoligotype
patterns using TB-insight RUN SPOTCLUST showed that the dominant lineages identified in
the present study were Euro-American and Central Asian genotypes consisting of 64 isolates
and 37 isolates, respectively.
Conclusion: This study confirmed the presence of known M. tuberculosis strains and revealed
new strains circulating in northwest Ethiopia and the distribution of the major phylogenetic
families. It thus contributes to a better understanding of the genotypic profile of M. tubercu-
losis strains circulating in Ethiopia.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Tuberculosis (TB), caused by the Mycobacterium tubercu-
losis complex (MTBC), is a serious infection in humans and
animals. M. tuberculosis belongs to a group of closely
related microorganisms known as the MTBC, which is a
group of genetically similar species, as defined by DNA/DNA
hybridization studies.1 The MTBC comprises seven mem-
bers, including M. tuberculosis, Mycobacterium bovis,
Mycobacterium africanum, Mycobacterium microti, Myco-
bacterium canettii, Mycobacterium pinnipedii, and Myco-
bacterium caprae.2e5 Although there is high genetic
homogeneity among the members, they display divergent
phenotypes, elicit different pathologies, and show some
degree of host specificities.
Both preventable and curable TB remains to be among
the world’s major causes of illness and death. In 1993, the
World Health Organization (WHO) declared TB as a global
health emergency. One-third of the world’s population
(i.e., 2 billion people) carries the TB bacteria; more than 9
million of them become sick with active TB each year, and
they can spread the disease to others.6
Currently, according to the Global Report 2010 by WHO,
Ethiopia ranks seventh among the high TB-burden countries
in the world, with an estimated incidence of 378 new cases
per 100,000 population per year. The estimated prevalence
of all forms of TB and smear-positive TB is 579 per 100,000
and 286 per 100,000 population, respectively. Even though
Ethiopia is one of the high TB-burden countries in Africa,
limited information is available on the genotypic charac-
teristics of M. tuberculosis strains infecting humans there.
In addition to being used in designing a more targeted
control measure, the availability of such information will
help study the phylogenetic characteristics of an organism,
which in turn will provide new insight into the natural his-
tory of M. tuberculosis.
In developing countries where the burden of TB is great-
est, few studies have been conducted and the application of
the new molecular epidemiology needs to be developed
further.7Molecular characterization ofM. tuberculosis strain
circulating in the community, for epidemiology, trans-
mission, and control of TB, is crucial in the control of the
disease. In addition, there is mounting evidence to suggest
that specific strains of M. tuberculosis belonging to discrete
phylogenetic clusters (lineages) may differ in virulence,
pathogenesis, andepidemiologic characteristics, all ofwhichmay impact TB control and vaccine development strategies
significantly.
The present study was aimed at characterizing Mycobac-
teria species isolated from patients with pulmonary TB from
Bahir Dar, Felege Hiwot Referral Hospital, Northwest
Ethiopia, and identifying the species, strains, and predomi-
nant lineages of strains that cause TB in the population.
Materials and methods
Study area
The study was conducted in Bahir Dar, which is the capital
city of Amhara National Regional State of Ethiopia, 565 km
away from Addis Ababa. The altitude of the area is 1802 m
above sea level and has an annual rain fall of 1703.4 mm;
the temperature of the city ranges from 12C to 27C. The
city has an estimated total population of 17,214,056
(8,636,875 males and 8,577,181 females).
8 The Felege
Hiwot Referral Hospital is a tertiary-level setup that pro-
vides referral services to over 12 million inhabitants in
northwest Ethiopia.
Study design
A cross-sectional study was conducted to characterize
mycobacterial isolates that were recovered from pulmo-
nary TB patients in Bahir Dar Felege Hiwot Referral Hospital
from October 2010 to June 2011. During the study period,
all patients suspected of TB visiting the hospital were used
as source population, whereas the study population con-
sisted of pulmonary TB patients with positive smear for
microscopic acid fast bacilli (AFB).
Sample collection and bacterial isolation
A total of 123 smear-positive sputum samples were
collected and processed during the study period.
Spotemorningespot sputum samples were collected, and
questionnaires were filled for each patient by trained lab-
oratory technologists. The specimens were labeled and
pooled together, kept in phosphate buffer saline (at pH 7.2
and a temperature of þ4C) in universal containers, and
then transported in ice pack box to Aklilu Lemma Institute
of Pathobiology (ALIPB), Addis Ababa (Ethiopia), within a
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tuberculosis according to the standard methods.9 In brief,
the sputum samples were decontaminated by shaking in an
equal volume of 4% NaOH for 15 minutes and concentrated
by centrifugation at 3000 rpm for 15 minutes. The sediment
was neutralized with 2N HCl, using phenol red as an indi-
cator. Bacteriological culturing of sputum samples was
performed using the conventional Lo¨wensteineJensen (LJ)
egg slant medium, containing 0.6% sodium pyruvate and
glycerol media, for the recommended time. Then the cul-
tures were incubated at 37C for 4e8 weeks and examined
on a weekly bases for the presence of any mycobacterial
colonies.
Microscopic examinations of the cultures using the
ZiehleNeelsen staining method were performed to select
AFB-positive isolates. AFB-positive isolates were prepared
by mixing two loops full of colonies in 200 mL distilled water,
heat-killed at 80C for 1 hour using water bath, and stored at
20C until molecular characterization was performed.Molecular typing
Region of difference 9 (RD9) deletion typing was per-
formed, as describe previously by Huard et al.10 The poly-
merase chain reaction (PCR) amplification mixtures used
for RD9 typing consisted of 10 mL HotStarTaqMaster Mix
(Qiagen, London, UK), 7.1 mL distilled H2O, 0.3 mL of each of
the three oligonucleotide primers (100 mM) [RD9Ff (50-GTG
TAG GTC AGC CCC ATC C-30), RD9Fr (50-GCC CAA CAG CTC
GAC ATC-30), and RD9Itn (50-CTG GAC CTC GAT GAC CAC TC-
30)], resulting in a total volume of 20 mL. The PCR reaction
mixture was heated at 95C for 15 minutes, after which it
was subjected to 35 cycles consisting of 95C for 1 minute,
55C for 1 minute, and 72C for 1 minute in the PCR ther-
mocycler (VWR, UK). Then the reaction mixture was
maintained at 72C for 10 minutes, and 0.8 mL of the PCR
product was mixed with 0.2 mLof a loading dye and loaded
onto 1% agarose gel, after which it was electrophoresed at
100 V and 500 mA for 60 minutes. The gel was visualized
using a computerized MultiImage Light Cabinet (VWR).
Interpretation of the result was based on the detection of
bands of different sizes. For a band size of 396 bp, the
isolate was considered as M. tuberculosis, whereas a band
size of 575 bp was considered to correspond to either M.
bovis or M. africanum. M. tuberculosis H37Rv and M. bovis
BCG were used as a positive control, whereas Qiagen
distilled water was used as a negative control.
Spoligotyping was performed following the method
described by Kamerbeek et al.11 The reaction mixture (total
volume of 25 mL) comprised 12.5 mL of HotStarTaq Master Mix
(Qiagen), 0.2 mL of each of the two primers (DRa and DRb),
5 mL suspension of heat-killed cells (approximately
10e50 ng), and 3.5 mL distilled water. The mixture was then
heated for 15minutes at 96Cand then subjected to 30 cycles
for 1 minute duration at 96C, 1 minute at 55C, and 30
seconds at 72C. At the end, the reaction mixture was
maintained at 72C for 10 minutes. The PCR products were
labeled with biotin because DRa primer is biotinylated.
Thereafter, 20 mL of amplified PCR product was mixed with
150 mL primary buffer, loaded on the miniblotter, and then
hybridized for 1 hour at 60C in the standard hybridizing oven(HP-1000 hybridizer, UVP, UK) to a set of 43 immobilized
oligonucleotides, each corresponding to one of the unique
spacer DNA sequences within the direct repeat locus. After
hybridization, the membrane (obtained from VLA-UK) was
washed twice in 250 mL secondary buffer at 60C for 10
minutes on a shaking platform. This was followed by cooling
of themembrane in distilled water; next, 2.5 mL streptavidin
peroxidase conjugate solution was added onto the mem-
brane and it was incubated for 1 hour at 42C in a hybridizing
oven. Thereafter, themembranewaswashed twice in 250mL
secondary buffer for 10 minutes at 42C by shaking
thoroughly, followed by two washes using 250 mL 2X SSPE
(saline-sodium phosphateeEDTA buffer) for 5 minutes at
roomtemperature. HybridizedDNAwas thendetected by the
enhanced chemiluminescence method and by exposure to
X-ray film, as specified by the manufacturer (Amersham-GE
Healthcare, UK).
Data management and analysis
All data generated during laboratory investigation were
double entered into Microsoft Excel. The web-based
SpolDB4 database (SITVIT database) is: http://
www.pasteur-guadeloupe.fr:8081/SITVITDemo/ was used
to assign the SIT (shared type) and the web-based
algorithm SPOTCLUST (http://tbinsight.cs.rpi.edu/run_
spotclust.html) was used to assign the lineages of each
isolates.
Results
Sociodemographic characteristics
Out of 123 AFB-positive sputum samples, 118 isolates were
culture positive (95.9%). The age of patients ranged from 15
years to 80 years (mean age, 31.85  1.05 years); the fe-
male to male sex ratio was 1:1.3. Of the 118 patients, 12
(10.2%) were HIV positive and 106 (89.8%) were HIV nega-
tive (Table 1).
Spoligotyping
Molecular characterization of isolates using RD9 deletion
typing showed all the 118 isolates were M. tuberculosis
(Fig. 1). These isolates were further characterized using
spoligotyping (Fig. 2). The spoligotyping analysis resulted in
the identification of 36 different spoligotype patterns, of
which 32 (88.9%) patterns have already been registered in
the spoligotype databases, SpolDB4 and SITVIT. However,
the remaining four (11.1%) patterns were not registered,
indicating that they were new spoligotypes of M. tubercu-
losis in Ethiopia. The isolates were further grouped into 17
clusters (99 isolates) and 19 nonclustered patterns. Out of
the 12 HIV-positive TB cases, 10 isolates belonged to clus-
tered patterns and only two isolates (SIT610 and NEW) were
among nonclustered patterns (Fig. 3). The most predomi-
nant spoligotypes were SIT25 and SIT53, consisting of 22
isolates and 14 isolates, respectively. SIT1729, SIT149, and
SIT289 accounted for seven isolates each. Classification of
the spoligotype patterns with web-based SPOTCLUST
Table 1 Characteristics of study participants (n Z 118)
Characteristics Frequency Percent
Sex
Male 66 55.9
Female 52 44.1
Age (y)
<20 6 5.1
20e40 93 78.8
41e60 17 14.4
>60 2 1.7
Address
Urban 45 38.1
Rural 73 61.9
HIV status
Reactive 12 10.2
Nonreactive 106 89.8
Previous anti-TB therapy
Yes 2 1.7
No 116 98.3
Anti-TB therapy outcome
Finished 1 0.8
Discontinued d d
Relapsed 1 0.8
Failure d d
TB Z tuberculosis.
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and 37 isolates in the Central Asian lineage (Fig. 2).Discussion
The present study describes the diversity of the population
structure of M. tuberculosis clinical isolates in patients
from northwest Ethiopia. All TB cases reported in this study
were caused by M. tuberculosis. Molecular characterizationFigure 1. Polymerase chain reaction banding pattern by RD9 de
bovis as 575-bp positive control; Lane 3Z H2O as negative control;
control; and Lanes 5e28 Z clinical isolates.of the strains of M. tuberculosis using spoligotyping iden-
tified 36 different spoligotype patterns, of which 17 (46%)
consisted of clusters of isolates whereas 19 (54%) consisted
of nonclustered single isolates. The most commonly found
M. tuberculosis strains were SIT25 and SIT53, which were
also reported earlier in the SITVIT database as the most
common types in Ethiopia by other researchers.12 In
agreement with our study, comparable prevalence of clus-
tering was found in population-based studies from South
Africa (45%),13 Botswana (42%),14 and Estonia (49%),15 and
among randomly sampled patients from Ethiopia (42.1%).12
Moreover, similar findings were reported in population-
based studies from Sub-Saharan Africa.16,17 None of the
isolates in the other 19 (54%) spoligotype patterns corre-
sponded to cluster strains. In agreement with other studies,
our study demonstrated higher frequency of clustered iso-
lates among HIV-positive TB patients.12,18 Interestingly, this
study showed the identification of four new strains of M.
tuberculosis belonging to the Euro-American lineage. One
of these new strains was from HIV-positive TB patients,
whereas the other three were from HIV-negative TB pa-
tients. In agreement with others,19 when the phylogenies of
the isolated M. tuberculosis strains were compared with
the current global M. tuberculosis distribution, most of the
strains were of the Euro-American lineages, followed by
those belonging to the Central Asian lineages.
In conclusion, this study has shown the presence of known
and new strains of M. tuberculosis circulating in northwest
Ethiopia and the distribution of the major phylogenetic
families. Thus, it contributes toabetter understanding of the
molecular epidemiology of M. tuberculosis in Ethiopia.
Generally, genotyping of M. tuberculosis isolates from
infected individuals can play an important role in tracking
the source of infection and disclosing the epidemiology of TB
outbreaks. This study also providedmolecular evidence for a
number of patients included in our study. However, it may
have been insufficient to confirm the prevalence of the most
circulating M. tuberculosis genotypes in Ethiopia. It will beletion typing. Lane 1 Z DNA ladder; Lane 2 Z Mycobacterium
Lane 4Z Mycobacterium tuberculosis H37Rv as 396-bp positive
Figure 2. Clusters of Mycobacterium tuberculosis clinical isolates determined by the spoligotyping method. The filled squares
depict positive hybridization signals and empty squares represent a lack of hybridization. CAS Z Central Asian; EA Z Euro-
American; IO Z Indo-Oceanic.
Figure 3. Spoligotype patterns of Mycobacterium tuberculosis clinical isolates from tuberculosis patients with HIV.
CAS Z Central Asian; EA Z Euro-American; IO Z Indo-Oceanic.
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